Dr. Andrew E. Aplin Awarded New Kalbach-Newton Professorship in Cancer Research
Jefferson’s newly endowed professorship was made possible through generous donations from the estates of Raymond B. Kalbach and Caroline Newton.
One of Jefferson’s leading cancer researchers, Andrew E. Aplin, PhD, is Associate Director for Basic Research and leader of the Cancer Cell Biology and Signaling Program at the Sidney Kimmel Cancer Center at Thomas Jefferson University. He is funded by the NIH/NCI to investigate skin melanoma and recently received a $1 million grant from the Dr. Ralph and Marian Falk Medical Research Trust for a team-based approach to investigate ocular melanoma.
This honor recognizes the numerous discoveries Dr. Aplin has made in the melanoma field, along with his significant leadership, education and mentoring roles at Jefferson over the years.
His investiture is planned for February 13, 2018.